By Senad Karaahmetovic Cowen analysts upgraded Regeneron (NASDAQ:REGN) to Outperform from Market Perform and hiked the price target to $875 per share from the prior $775 as the...
(Bloomberg) -- The US economy grew faster than expected in the last quarter of 2022, but the mixed GDP report also showed consumer spending that was slower than forecast,...
Nation’s Most Innovative Teens will Showcase Research with Prizes of Over $1.8 million TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Regeneron...
investor.regeneron.com. To participate via telephone, please register in advance at this link.
Let's be frank: The third quarter was a mess for stocks. It doesn't much matter where the stocks were traded, except this: U.S. stocks in September were not a place you wanted to...
Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.
Average | 811.96 (+10.25% Upside) |
High | 1,023.00 |
Low | 605.00 |
Price | 736.46 |
No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Buy | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Buy | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Buy | Neutral | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
0.011 | 0.011 | 0.01 | +0.001 | +4.76% | 2.69M | Sydney | |||
0.18 | 0.195 | 0.18 | -0.010 | -5.26% | 280.08K | Sydney | |||
49.38 | 49.89 | 49.285 | +0.150 | +0.30% | 6.82M | Sydney | |||
1.85 | 1.865 | 1.81 | +0.040 | +2.21% | 1.38M | Sydney | |||
0.086 | 0.087 | 0.082 | 0.00 | 0.00% | 0.00 | Sydney | |||
5.78 | 7.25 | 5.51 | -1.90 | -24.74% | 7.78M | Sydney | |||
0.022 | 0.023 | 0.022 | 0.00 | 0.00% | 0.00 | Sydney | |||
4.50 | 4.62 | 4.43 | -0.11 | -2.39% | 422.32K | Sydney | |||
0.011 | 0.012 | 0.011 | 0.00 | 0.00% | 0.00 | Sydney | |||
4.75 | 4.96 | 4.67 | -0.250 | -5.00% | 35.40M | Sydney | |||
22.24 | 22.55 | 22.13 | +0.050 | +0.23% | 6.98M | Sydney | |||
0.008 | 0.009 | 0.008 | -0.001 | -11.11% | 15.64M | Sydney | |||
0.012 | 0.012 | 0.012 | 0.00 | 0.00% | 1.64M | Sydney | |||
0.054 | 0.056 | 0.052 | -0.002 | -3.57% | 1.52M | Sydney | |||
126.64 | 127.83 | 126.01 | +1.120 | +0.89% | 1.53M | Sydney |